{"name":"Egis Pharmaceuticals","slug":"egis","ticker":"Private","exchange":"Private (Servier subsidiary)","domain":"egis.hu","description":"Egis Pharmaceuticals is a private generic and specialty pharmaceutical company with a focus on therapeutic areas such as cardiovascular and central nervous system diseases. The company's key products include generics and specialty pharmaceuticals. Egis operates in multiple markets, including the US, Europe, and Asia.","hq":"Budapest, Hungary","founded":0,"employees":"","ceo":"Csaba Poroszlai","sector":"Generics / Specialty Pharma","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$2.5B (estimated)","metrics":{"revenue":1600000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Amlodipine patent cliff ($1.4B at risk)","drug":"Amlodipine","type":"patent_expiry","sentiment":"negative"},{"date":"2029-06-01","label":"Metoprolol Succinate patent cliff ($1.1B at risk)","drug":"Metoprolol Succinate","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"deal","headline":"Egis Pharmaceuticals Acquires Rights to Develop and Commercialize Generic Version of Amlodipine","summary":"Egis Pharmaceuticals has acquired the rights to develop and commercialize a generic version of Amlodipine, a widely used antihypertensive medication.","drugName":"Amlodipine","sentiment":"positive"},{"date":"2023-08-15","type":"regulatory","headline":"Egis Pharmaceuticals Receives FDA Approval for Generic Version of Metoprolol Succinate","summary":"Egis Pharmaceuticals has received FDA approval for its generic version of Metoprolol Succinate, a medication used to treat high blood pressure and heart failure.","drugName":"Metoprolol Succinate","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE9fRlN2UU1OTlBBVEpLM3lvdkg0TmxleDk2WjJGb1dHc1VhMVpjd3RwS1lkcXBGUjJ3N3hjVHRtclpTNHFQWUNQUVo5ZjdhSnNLWTBidUVJWlNIdw?oc=5","date":"2025-05-07","type":"pipeline","source":"AzerNews","summary":"Scandens as turning point in development of Azerbaijan's Pharmaceutical Industry - AzerNews","headline":"Scandens as turning point in development of Azerbaijan's Pharmaceutical Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPZnNuT0haaTRXS0RLY2Izd0lvTFZhMTBrVDRDYlNVbEZOV0k4ZDZZekVYcG5IazdmYXJrT2prbDBNSHhfLUtQMlRBUm9VWkljZkZsdWhvQVBKeloxdGZuUmVFWTRFNk1hSGRuMk9SZGpJMHYybWFYa2VsWWpFSGtDOV9VeVZaNWNfeUFEck81VmduVjhadW5WOEpXOXV1eFJabHNkdVlaM0RKTXk4bG1uMVpPUnVYUDVwcWRoYmstc0M3bXlwcm9uUE9DcDlSLVU?oc=5","date":"2023-06-25","type":"pipeline","source":"finchannel","summary":"Suprastin Becomes Georgian Consumers’ Favorite Allergy Remedy - finchannel","headline":"Suprastin Becomes Georgian Consumers’ Favorite Allergy Remedy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOczNiZlJiMWFielNzaXN4TEQ5MTNOV3RlYWhqZmtyeE5WZnoxUWt0akJ5UC02MmRoSDJYUHpkMEFWX1FlQXE1ZWpwMWw0ekZPbDh6N2NkM2d4MldXWmFuRmxjZFNuR3lkWlhIdEpNY2JBR3hPTUlhWWNMM0liWUJaUnFpYVVwTW04b2hN?oc=5","date":"2019-06-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets - Pharmaceutical Technology","headline":"Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets","sentiment":"neutral"}],"patents":[{"drugName":"Amlodipine","drugSlug":"amlodipine-besylate","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1400000000},{"drugName":"Metoprolol Succinate","drugSlug":"metoprolol-succinate","patentNumber":"","type":"Patent Cliff","expiryDate":"2029-06-01","territory":"US","annualRevenue":1100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sandoz","Mylan","Teva Pharmaceuticals"],"therapeuticFocus":["Cardiovascular","Central Nervous System"],"financials":null,"yahoo":null}